top of page
News
ARCO and the University of Rome Tor Vergata publish the first Italian study on the societal costs of chronic spontaneous urticaria
The article "The societal costs associated with patients with chronic spontaneous urticaria (CSU) in Italy" has been published in the international scientific journal Global & Regional Health Technology Assessment (GRHTA) (DOI: 10.33393/grhta.2026.3703). This is the first study conducted in Italy to estimate the indirect costs and out-of-pocket expenses borne by patients with chronic spontaneous urticaria (CSU) — a milestone of significant scientific and social value. A study
Apr 42 min read
Together for Care: where science meets humanity
Together for Care is more than the title of an event — it’s a message about collaboration, empathy, and shared value. On Oct 4 2025, at...
Oct 11, 20251 min read
Meyer recognized as a UCARE center for pediatric chronic urticaria. ARCO announces a new collaboration
ARCO – Association for Research and Care of Urticaria is pleased to share with its members and Italian patients news of great importance...
Sep 6, 20251 min read
Xolair Now Available in Pharmacies: A Breakthrough for Patients with Chronic Spontaneous Urticaria (CSU) in Lombardy
Starting August 4, 2025 , a new simplified process for prescribing and dispensing the biological drug omalizumab (Xolair) , used in the...
Aug 6, 20251 min read
bottom of page